Abstract
Bone metastases are a common complication of advanced cancer that can cause severe and debilitating effects. External beam radiation therapy (EBRT) provides significant palliation of painful bone metastases in around 70% of patients, induces remineralization, prevents impending fractures, and promotes healing of pathological fractures, reducing the skeletal-related events (SRE). Hypofractionated schedules are used for the treatment of bone metastases; the most commonly used are a single 8 Gy, 20 Gy in five daily treatments (4 Gy per treatment), and 30 Gy in ten daily treatments (3 Gy per treatment). Postoperative external beam irradiation can significantly reduce disease progression and subsequent loss of fixation. In the postoperative setting, the treatment field should include the entire interlocking device, nails, or prosthesis in order to remove any microscopic dissemination of disease. Two-dimensional or 3D conformal radiotherapy could be used for treatment planning. Simple field assessment (anteroposterior-posteroanterior AP-PA field) is often used for treatment planning of long bones, leading to a shorter treatment time. For pelvic bone metastases, a more complex field assessment could be considered to lessen the dose to the organs at risk, leading to a better tolerability of the treatment itself. Recent technological advances, such as intensity-modulated radiotherapy (IMRT) and stereotactic body radiotherapy (SBRT), can be used in a particular setting of oligometastatic patients to deliver a substantial dose of radiation to the tumor and spare healthy normal tissues.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011;79(4):965–76. https://doi.org/10.1016/j.ijrobp.2010.11.026.
Kakhki VR, Anvari K, Sadeghi R, Mahmoudian AS, Torabian-Kakhki M. Pattern and distribution of bone metastases in common malignant tumors. Nucl Med Rev Cent East Eur. 2013;16(2):66–9. https://doi.org/10.5603/NMR.2013.0037.
Bauer HC. Controversies in the surgical management of skeletal metastases. J Bone Joint Surg Br. 2005;87(5):608–17.
Canale ST, Beaty HJ. Campbell’s operative orthopaedics. 12th ed. Oxford: Mosby Elsevier; 2013.
Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s–9s.
Mantyh P. Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain. 2013;154(Suppl 1):S54–62. https://doi.org/10.1016/j.pain.2013.07.044. Epub 2013 Jul 31
Pituskin E, Fairchild A, Dutka J, Gagnon L, Driga A, Tachynski P, et al. Multidisciplinary team contributions within a dedicated outpatient palliative radiotherapy clinic: a prospective descriptive study. Int J Radiat Oncol Biol Phys. 2010;78(2):527–32.
Chow E, Wong R, Hruby G, Connolly R, Franssen E, Fung KW, et al. Prospective patient-based assessment of effectiveness of palliative radiotherapy for bone metastases. Radiother Oncol. 2001;61:77–82.
McDonald R, Chow E, Rowbottom L, Bedard G, Lam H, Wong E, et al. Quality of life after palliative radiotherapy in bone metastases: a literature review. J Bone Oncol. 2014;4(1):24–31. https://doi.org/10.1016/j.jbo.2014.11.001.
Hoskin PJ. Bisphosphonates and radiation therapy for palliation of metastatic bone disease. Cancer Treat Rev. 2003;29(4):321–7.
Saarto T, Janes R, Tenhunen M, Kouri M. Palliative radiotherapy in the treatment of skeletal metastases. Eur J Pain. 2002;6(5):323–30.
Poulsen HS, Nielsen OS, Klee M, Rørth M. Palliative irradiation of bone metastases. Cancer Treat Rev. 1989;16(1):41–8.
Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain. 1997;69(1–2):1–18.
Tsay TP, Chen MH, Oyen OJ, Hahn SS, Marty JJ. The effect of cobalt-60 irradiation on bone marrow cellularity and alveolar osteoclasts. Proc Natl Sci Counc Repub China B. 1995;19(3):185–95.
Vakaet LA, Boterberg T. Pain control by ionizing radiation of bone metastasis. Int J Dev Biol. 2004;48(5–6):599–606.
Cliffoard Chao KS, Perez CA, Brady LW. Radiation oncology management decisions. Philadelphia: Lippincott Williams & Wilkins; 2002.
Fletcher GH. Textbook of radiotherapy. Philadelphia: Lea & Febiger; 1980. p. 943–6.
Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group. Cancer. 1982;50(5):893–9.
Hirokawa Y, Wadasaki K, Kashiwado K, Kagemoto M, Katsuta S, Honke Y, et al. A multi-institutional prospective randomized study of radiation therapy of bone metastases. Nihon Igaku Hoshasen Gakkai Zasshi. 1988;48(11):1425–31.
Rasmusson B, Vejborg I, Jensen AB, Andersson M, Banning AM, Hoffmann T, et al. Irradiation of bone metastases in breast cancer patients: a randomized study with 1 year follow-up. Radiother Oncol. 1995;34(3):179–84.
Niewald M, Tkocz HJ, Abel U, Scheib T, Walter K, Nieder C, et al. Rapid course radiation therapy vs. more standard treatment: a randomized trial for bone metastases. Int J Radiat Oncol Biol Phys. 1996;36(5):1085–9.
Wu JS, Wong R, Johnston M, Bezjak A, Whelan T, Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group. Meta-analysis of dose-fraction radiotherapy trias for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003;55(3):594–605.
Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD. Palliation of metastatic bone pain; single fraction versus multifraction radiotherapy: a systemic review of randomized trials. Clin Oncol (R Coll Radiol). 2003;15(6):345–52.
Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: systematic review. J Clin Oncol. 2007;25(11):1423–36.
Chow E, Zeng L, Salvo N, Dennis K, Tsao M, Lutz S. Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol). 2012;24(2):112–24. https://doi.org/10.1016/j.clon.2011.11.004.
Westhoff PG, de Graeff A, Monninkhof EM, Bollen L, Dijkstra SP, van der Steen-Banasik EM, et al. An easy tool to predict survival in patients receiving radiation therapy for painful bone metastases. Int J Radiat Oncol Biol Phys. 2014;90(4):739–47. https://doi.org/10.1016/j.ijrobp.2014.07.051.
Sim FH. Metastatic bone disease of the pelvis and femur. Instr Course Lect. 1992;41:317–27.
Bonarigo BC, Rubin P. Nonunion of pathologic fracture after radiation therapy. Radiology. 1967;88(5):889–98.
Frassica FJ, Frassica DA. Metastatic bone disease of the humerus. J Am Acad Orthop Surg. 2003;11(4):282–8.
Jacofsky DJ, Haidukewych GJ. Management of pathologic fractures of the proximal femur: state of the art. J Orthop Trauma. 2004;18(7):459–69.
Bickels J, Dadia S, Lidar Z. Surgical management of metastatic bone disease. J Bone Joint Surg Am. 2009;91(6):1503–16. https://doi.org/10.2106/JBJS.H.00175.
Biermann JS, Holt GE, Lewis VO, Schwartz HS, Yaszemski MJ. Metastatic bone disease: diagnosis, evaluation, and treatment. Instr Course Lect. 2010;59:593–606.
Ruggieri P, Mavrogenis AF, Casadei R, Errani C, Angelini A, Calabrò T, et al. Protocol of surgical treatment of long bone pathological fractures. Injury. 2010;41(11):1161–7. https://doi.org/10.1016/j.injury.2010.09.018.
Malviya A, Gerrand C. Evidence for orthopaedic surgery in the treatment of metastatic bone disease of the extremities: a review article. Palliat Med. 2012;26(6):788–96. https://doi.org/10.1177/0269216311419882.
Quinn RH, Randall RL, Benevenia J, Berven SH, Raskin KA. Contemporary management of metastatic bone disease: tips and tools of the trade for general practitioners. Instr Course Lect. 2014;63:431–41.
Willeumier JJ, van der Linden YM, Dijkstra PD. Lack of clinical evidence for postoperative radiotherapy after surgical fixation of impending or actual pathologic fractures in the long bones in patients with cancer; a systematic review. Radiother Oncol. 2016;121(1):138–42. https://doi.org/10.1016/j.radonc.2016.07.009.
Gunderson T. Clinical radiation oncology. 2nd ed. Philadelphia: Churchill Livingstone Elsevier; 2007.
Hoskin P, Goh V. Radiotherapy in practice—imaging. Oxford: Oxford University press; 2010. p. 260–1.
Taylor A, Powell ME. Intensity-modulated radiotherapy—what is it? Cancer Imaging. 2004;4(2):68–73. https://doi.org/10.1102/1470-7330.2004.0003.
Griffioen G, Dahele M, Jeulink M, Senan S, Slotman B, Verbakel WF. Bowel-sparing intensity-modulated radiotherapy (IMRT) for palliation of large-volume pelvic bone metastases: rationale, technique and clinical implementation. Acta Oncol. 2013;52(4):877–80. https://doi.org/10.3109/0284186X.2012.725943.
Bhattacharya IS, Hoskin PJ. Stereotactic body radiotherapy for spinal and bone metastases. Clin Oncol (R Coll Radiol). 2015;27(5):298–306. https://doi.org/10.1016/j.clon.2015.01.030.
Kim H, Rajagopalan MS, Beriwal S, Huq MS, Smith KJ. Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases. Int J Radiat Oncol Biol Phys. 2015;91(3):556–63.
Gomez-Iturriaga A, Cacicedo J, Navarro A, Morillo V, Willisch P, Carvajal C, et al. Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study. BMC Palliat Care. 2015;14:48. https://doi.org/10.1186/s12904-015-0045-8.
Chow E, Meyer RM, Ding K, Nabid A, Chabot P, Wong P. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial. Lancet Oncol. 2015;16(15):1463–72. https://doi.org/10.1016/S1470-2045(15)00199-0.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Fiore, M., Rinaldi, C.G., Ramella, S. (2019). The Role of Radiotherapy in Long Bone Metastases and Pelvis. In: Denaro, V., Di Martino, A., Piccioli, A. (eds) Management of Bone Metastases. Springer, Cham. https://doi.org/10.1007/978-3-319-73485-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-73485-9_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73484-2
Online ISBN: 978-3-319-73485-9
eBook Packages: MedicineMedicine (R0)